93 related articles for article (PubMed ID: 22682546)
1. Immunohistochemical and morphometric evaluation of neuronal dysfunction in pelviureteral junction obstruction.
Gündüz M; Yurtçu M; Toy H; Abasiyanik A; Demirci S
J Pediatr Urol; 2013 Jun; 9(3):359-63. PubMed ID: 22682546
[TBL] [Abstract][Full Text] [Related]
2. Glial cell line-derived neurotrophic factor and synaptophysin expression in pelviureteral junction obstruction.
Demirbilek S; Edali MN; Gürünlüoğlu K; Türkmen E; Taş E; Karaman A; Akin M; Aksoy RT; Celbis O; Uzün I
Urology; 2006 Feb; 67(2):400-5. PubMed ID: 16461096
[TBL] [Abstract][Full Text] [Related]
3. Neuronal defects an etiological factor in congenital pelviureteric junction obstruction?
How GY; Chang KTE; Jacobsen AS; Yap TL; Ong CCP; Low Y; Allen JC; Kuick CH; Lim MZL; Laksmi NK
J Pediatr Urol; 2018 Feb; 14(1):51.e1-51.e7. PubMed ID: 28927720
[TBL] [Abstract][Full Text] [Related]
4. Abnormal innervation and altered nerve growth factor messenger ribonucleic acid expression in ureteropelvic junction obstruction.
Wang Y; Puri P; Hassan J; Miyakita H; Reen DJ
J Urol; 1995 Aug; 154(2 Pt 2):679-83. PubMed ID: 7609154
[TBL] [Abstract][Full Text] [Related]
5. Investigation of histopathologic changes in pelviureteral junction obstruction.
Yurtçu M; Gürbüzer N; Findik S; Avunduk MC; Günel E
Ren Fail; 2010 Jan; 32(2):162-6. PubMed ID: 20199176
[TBL] [Abstract][Full Text] [Related]
6. Smooth muscle cell apoptosis and defective neural development in congenital ureteropelvic junction obstruction.
Kajbafzadeh AM; Payabvash S; Salmasi AH; Monajemzadeh M; Tavangar SM
J Urol; 2006 Aug; 176(2):718-23; discussion 723. PubMed ID: 16813927
[TBL] [Abstract][Full Text] [Related]
7. Postnatal unilateral pelviureteral junction obstruction: impact of pyeloplasty and conservative management on renal function.
Shokeir AA; El-Sherbiny MT; Gad HM; Dawaba M; Hafez AT; Taha MA; Saida M; Ghaly AM
Urology; 2005 May; 65(5):980-5; discussion 985. PubMed ID: 15882736
[TBL] [Abstract][Full Text] [Related]
8. Distribution of Cajal like cells and innervation in intrinsic ureteropelvic junction obstruction.
Kuvel M; Canguven O; Murtazaoglu M; Albayrak S
Arch Ital Urol Androl; 2011 Sep; 83(3):128-32. PubMed ID: 22184836
[TBL] [Abstract][Full Text] [Related]
9. Altered expression of interstitial cells of Cajal in congenital ureteropelvic junction obstruction.
Solari V; Piotrowska AP; Puri P
J Urol; 2003 Dec; 170(6 Pt 1):2420-2. PubMed ID: 14634443
[TBL] [Abstract][Full Text] [Related]
10. Coexisting pelviureteral and vesicoureteral junction obstruction in children.
Pesce C; Musi L; Campobasso P; Costa L; Fabbro M
Eur J Pediatr Surg; 2003 Dec; 13(6):367-71. PubMed ID: 14743322
[TBL] [Abstract][Full Text] [Related]
11. Pelviureteral junction obstruction: correlation of renal cell apoptosis and differential renal function.
Lama G; Ferraraccio F; Iaccarino F; Luongo I; Marte A; Rambaldi PF; Esposito-Salsano M
J Urol; 2003 Jun; 169(6):2335-8. PubMed ID: 12771794
[TBL] [Abstract][Full Text] [Related]
12. Intrarenal cystic mass with pelviureteral junction obstruction.
Moon D; Frydenberg A; Dewan PA
Urology; 2000 May; 55(5):775. PubMed ID: 10792109
[TBL] [Abstract][Full Text] [Related]
13. Altered expression of interstitial cells of Cajal in primary obstructive megaureter.
Kart Y; Karakuş OZ; Ateş O; Hakgüder G; Olguner M; Akgür FM
J Pediatr Urol; 2013 Dec; 9(6 Pt B):1028-31. PubMed ID: 23498667
[TBL] [Abstract][Full Text] [Related]
14. Structural changes of smooth muscle in congenital ureteropelvic junction obstruction.
Hosgor M; Karaca I; Ulukus C; Ozer E; Ozkara E; Sam B; Ucan B; Kurtulus S; Karkiner A; Temir G
J Pediatr Surg; 2005 Oct; 40(10):1632-6. PubMed ID: 16226997
[TBL] [Abstract][Full Text] [Related]
15. Early alteration of urinary exosomal aquaporin 1 and transforming growth factor β1 after release of unilateral pelviureteral junction obstruction.
Li ZZ; Zhao ZZ; Wen JG; Xing L; Zhang H; Zhang Y
J Pediatr Surg; 2012 Aug; 47(8):1581-6. PubMed ID: 22901921
[TBL] [Abstract][Full Text] [Related]
16. Altered anoctamin-1 and tyrosine phosphorylation in congenital ureteropelvic junction obstruction.
Hunziker M; O'Donnell AM; Gosemann J; Alvarez LA; Puri P
J Pediatr Surg; 2020 Aug; 55(8):1621-1625. PubMed ID: 32087933
[TBL] [Abstract][Full Text] [Related]
17. Altered cytoskeletal structure of smooth muscle cells in ureteropelvic junction obstruction.
Cutroneo G; Arena S; Anastasi G; Cervellione RM; Grimaldi S; Di Mauro D; Speciale F; Arena F; Di Benedetto V; Favaloro A; Magno C
J Urol; 2011 Jun; 185(6):2314-9. PubMed ID: 21511284
[TBL] [Abstract][Full Text] [Related]
18. The association between impaired autophagy and the development of congenital ureteropelvic junction obstruction.
Tourchi A; Kajbafzadeh AM; Ebadi M; Tavangar SM; Jarooghi N
Urology; 2014 Dec; 84(6):1467-74. PubMed ID: 25440825
[TBL] [Abstract][Full Text] [Related]
19. [Thickness of the renal pelvis smooth muscle indicates the postoperative course of ureteropelvic junction obstruction treatment].
Kaselas C; Aggelidou S; Papouis G; Kazakis C; Philippopoulos A
Actas Urol Esp; 2011; 35(10):605-9. PubMed ID: 21831482
[TBL] [Abstract][Full Text] [Related]
20. Minimally invasive surgery for pelviureteral junction obstruction in adults: a critical review of the options.
Manikandan R; Saad A; Bhatt RI; Neilson D
Urology; 2005 Mar; 65(3):422-32. PubMed ID: 15780349
[No Abstract] [Full Text] [Related]
[Next] [New Search]
